• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

MRK-560

CAS No. 677772-84-8

MRK-560 ( —— )

产品货号. M26763 CAS No. 677772-84-8

MRK-560 是一种有效的脑渗透性 γ-分泌酶抑制剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1037 有现货
10MG ¥1596 有现货
25MG ¥3216 有现货
50MG ¥5014 有现货
100MG ¥7152 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    MRK-560
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    MRK-560 是一种有效的脑渗透性 γ-分泌酶抑制剂。
  • 产品描述
    MRK-560 is an effective and brain-penetrant inhibitor of γ-secretase.
  • 体外实验
    MRK-560 (30, 100, 300, 1000 nM; 15days) blocks mutant NOTCH1 receptor signaling in human T-ALL cell lines.Cell Proliferation Assay Cell Line:HPB-ALL, DND-41, and Jurkat cells Concentration:30, 100, 300, 1000 nM Incubation Time:15 days Result:Reduced NICD1 generation in cells and resulted in a dose-dependent decrease of proliferation in HPB-ALL and DND-41, which depend on NOTCH signaling for their survival.
  • 体内实验
    MRK-560 (15.54 mg/kg; S.C.; single daily for 14 days) shows strong antileukemic effects on T-ALL model.MRK-560 (1, 3, 10, 30, 100 mg/kg; p.o.; single) shows good blood-brain barrier permeability in a dose-dependent manner in rats.MRK-560 (1, 3, 10, 30, 100 mg/kg; p.o.; single) inhibits the production of Aβ levels in brain and cerebrospinal fluid.MRK-560 (1 mg/kg; p.o.; single) shows a good bioavailability of 70 to 90%, and Tmax is 12 h.MRK-560 (1 mg/kg; i.v.; single) is suitable for once-a-day dosing (with a low plasma clearance and a half-life of more than 15 h). Animal Model:Tg (HLA-DRB1) 31Dmz/Szj (NSG) mice (T-ALL (T cell acute lymphoblastic leukemia) model).Dosage:15.54 mg/kg Administration:Subcutaneous injection; single daily for 14 days. Result:Resulted in strong antileukemic effects and improved median survival to 30 days compared to 18 days in vehicle-treated mice.Animal Model:Male Sprague-Dawley rats (250-300 g).Dosage:1, 3, 10, 30, 100 mg/kg Administration:Oral administration; single (experiment is performed 8 h later)Result:Increased the plasma and brain concentrations in a dose-dependent manner.Reduced (dose-dependent) both brain and CSF Aβ levels, with essentially complete inhibition of the production of both peptides being observed at a dose of 100 mg/kg.Animal Model:Male Sprague-Dawley rats (250-300 g).Dosage:1 mg/kg Administration:Intravenously and orally administration; single.Result:Showed Tmax after the oral dose was 12 h,and bioavailability was 70 to 90%.Revealed a low plasma clearance of less than 5 mL/min/kg with a volume of distribution of approximately 6 L/kg, which translated to a long half-life of more than 15 h.
  • 同义词
    ——
  • 通路
    Neuroscience
  • 靶点
    Gamma-secretase
  • 受体
    KEAP1-Nrf2
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    677772-84-8
  • 分子量
    517.91
  • 分子式
    C19H17ClF5NO4S2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 100 mg/mL (193.08 mM)
  • SMILES
    Fc1ccc(F)c(c1)[C@]1(CC[C@@H](CC1)NS(=O)(=O)C(F)(F)F)S(=O)(=O)c1ccc(Cl)cc1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Richard Steel, et al. Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction. ACS Med Chem Lett. 2012 May 10;3(5):407-410.
产品手册
关联产品
  • Aβ-IN-1

    Aβ-IN-1 is a novel, potent and orally active γ-secretase modulator (GSM). Aβ-IN-1 potently reduced Aβ42 levels with an IC 50 value of 0.091 μM in cultured cells without inhibiting CYP3A4. Aβ-IN-1 shows a sustained pharmacokinetic profile.

  • CB-103

    CB-103是一种口服活性的Notch信号通路抑制剂,具有抗肿瘤活性。 CB-103 在人 T 细胞急性淋巴细胞白血病癌细胞系中表现出阻断 NOTCH 信号传导的能力,并在 GSI 耐药 T-ALL 细胞系中表现出抗肿瘤功效。

  • NVP-TNKS656

    NVP-TNKS656 是一种高效、选择性、口服活性的 TNKS2 抑制剂。